Resistance in Respiratory Tract Pathogens of Children During 2000~2002

王传清,王岱明,王爱敏,薛建昌,宋建明
DOI: https://doi.org/10.3760/j:issn:1009-9158.2004.02.021
2004-01-01
Abstract:Objective To investigate the percentage of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus isolated from children with actual respiratory tract infection. The resistance to the three isloates,the serotyping of Streptococcus pneumoniae and the β-lactamase-prouding of Hemophilus influenzae, Moraxella catarrhalis,and Streptococcus pneumoniae. Methods Haemophilus influenzae,Moraxella catarrhalis,and Streptococcus pneumoniae were identified by chemistry reaction . The β-lactamase was detected by Nitrocefin disc. Antibiotic susceptibility test was performed by E test and Kirby-Bauer disk diffusion method. Serotyping of Streptococcus pneumoniae was carried out by capsule swelling test. Results The isolates of Haemophilus influenzae were more than other pathogens during 3 years, and about 20% of Haemophilus influenzae were resistant to Ampicillin. The isolates of Moraxella catarrhalis and Streptococcus pneumoniae were gradually raising. β-lactamase-prouding test indicated that 17.2% of Haemophilus influenzae and 95.1% of Moraxella catarrhalis were β-lactamase positive ,and 72.7% Moraxella catarrhalis of β-lactamase-prouding were resistant to Ampicillin. Eleven serotypes of Streptococcus pneumoniae were found, and 19F, 23F were the main serotypes .Antibiotic susceptibility test showed that only 4.2% of Streptococcus Pneumoniae were resistant to penicillin (PRSP). Conclusions The Hamophilus influenzae , Moraxella catarrhalis , and Streptococcus pneumoniae have been the important community acquired pathogens. The main serotypes of Streptococcus pneumoniae were 19F,23F during the 3 years .The Penicillin was still used for the treatment of the Haemophilus influenzae and Streptococcus pneumoniae infection isolated from respiration tract, but it was not so effective in the treatment of Moraxella catarrhal infection. Several antimicrobial agents can be used to treat Moraxella catarrhali infection, such as cephlosporins ,macrolides, β-lactam and β-lactamase inhibitor combinant, quinolones and SMZ/TMP.
What problem does this paper attempt to address?